Intelligent Bio Solutions, Inc. (INBS)
1.51
-0.02
(-1.31%)
USD |
NASDAQ |
Oct 12, 13:01
Intelligent Bio Solutions Price to Book Value : 0.7962 for Oct. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 0.8067 |
| October 08, 2026 | 0.8278 |
| October 07, 2026 | 0.8383 |
| October 06, 2026 | 0.8331 |
| October 05, 2026 | 0.8805 |
| October 02, 2026 | 0.8752 |
| October 01, 2026 | 0.8752 |
| September 30, 2026 | 0.8805 |
| September 29, 2026 | 0.8594 |
| September 28, 2026 | 0.87 |
| September 25, 2026 | 0.8963 |
| September 24, 2026 | 0.9016 |
| September 23, 2026 | 0.9332 |
| September 22, 2026 | 0.9491 |
| September 21, 2026 | 0.9543 |
| September 18, 2026 | 1.028 |
| September 17, 2026 | 1.054 |
| September 16, 2026 | 1.039 |
| September 15, 2026 | 1.081 |
| September 14, 2026 | 1.091 |
| September 11, 2026 | 1.123 |
| September 10, 2026 | 1.155 |
| September 09, 2026 | 1.181 |
| September 08, 2026 | 1.134 |
| September 04, 2026 | 1.176 |
| Date | Value |
|---|---|
| September 03, 2026 | 1.213 |
| September 02, 2026 | 1.302 |
| September 01, 2026 | 1.281 |
| August 31, 2026 | 1.265 |
| August 28, 2026 | 1.244 |
| August 27, 2026 | 1.197 |
| August 26, 2026 | 1.192 |
| August 25, 2026 | 1.244 |
| August 24, 2026 | 1.318 |
| August 21, 2026 | 1.323 |
| August 20, 2026 | 1.397 |
| August 19, 2026 | 1.408 |
| August 18, 2026 | 1.698 |
| August 17, 2026 | 1.777 |
| August 14, 2026 | 1.460 |
| August 13, 2026 | 1.582 |
| August 12, 2026 | 1.339 |
| August 11, 2026 | 1.081 |
| August 10, 2026 | 1.033 |
| August 07, 2026 | 1.044 |
| August 06, 2026 | 1.049 |
| August 05, 2026 | 0.9438 |
| August 04, 2026 | 0.9543 |
| August 03, 2026 | 0.9596 |
| July 31, 2026 | 0.9543 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Sanara MedTech, Inc. | 40.62 |
| Anteris Technologies Global Corp. | 2.557 |
| 20/20 Biolabs, Inc. | 2.872 |
| Quest Diagnostics, Inc. | 3.408 |
| Labcorp Holdings, Inc. | 2.963 |
Price to Book Value Related Metrics
| PS Ratio | 0.5647 |
| Price | 1.51 |
| Earnings Yield | -625.6% |
| Market Cap | 4.387M |